14-3-3sigma mediation of cell cycle progression is p53-independent in response to insulin-like growth factor-I receptor activation (Q40547508)

21 September 2017

14-3-3sigma mediation of cell cycle progression is p53-independent in response to insulin-like growth factor-I receptor activation (English)

1 reference

21 September 2017

5

Derek LeRoith

1 reference

21 September 2017

Yang Zhang

1

1 reference

21 September 2017

Michael Karas

series ordinal

2

1 reference

21 September 2017

Hong Zhao

series ordinal

3

1 reference

21 September 2017

Shoshana Yakar

series ordinal

4

1 reference

21 September 2017

language of work or name

English

0 references

publication date

8 June 2004

1 reference

Journal of Biological Chemistry

21 September 2017

1 reference

21 September 2017

279

1 reference

21 September 2017

34353-34360

1 reference

21 September 2017

33

1 reference

The IGF-I receptor in cancer research

21 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

The constitutively active mutant Galpha13 transforms mouse fibroblast cells deficient in insulin-like growth factor-I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

Role of IRS-2 in insulin and cytokine signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

Characterization of insulin receptor substrate 4 in human embryonic kidney 293 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

Mitogenic signaling of insulin-like growth factor I in MCF-7 human breast cancer cells requires phosphatidylinositol 3-kinase and is independent of mitogen-activated protein kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

Epidermal growth factor induces cyclin D1 in a human prostate cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

Thyrotropin induces G1 cyclin expression and accelerates G1 phase after insulin-like growth factor I stimulation in FRTL-5 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

Insulin/insulin-like growth factor-I and estrogen cooperate to stimulate cyclin E-Cdk2 activation and cell Cycle progression in MCF-7 breast cancer cells through differential regulation of cyclin E and p21(WAF1/Cip1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

IGF-1 activates p21 to inhibit UV-induced cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

Molecular evolution of the 14-3-3 protein family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

14-3-3 proteins; bringing new definitions to scaffolding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

14-3-3 proteins interact with specific MEK kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

Activation of Raf-1 by 14-3-3 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

The MAP kinase kinase kinase MLK2 co-localizes with activated JNK along microtubules and associates with kinesin superfamily motor KIF3

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

14-3-3 zeta protein binds to the carboxyl half of mouse wee1 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

Suppression of apoptosis signal-regulating kinase 1-induced cell death by 14-3-3 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

Phosphatidylinositol 3-kinase signaling inhibits DAF-16 DNA binding and function via 14-3-3-dependent and 14-3-3-independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

14-3-3sigma is a p53-regulated inhibitor of G2/M progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

ATR and ATRIP: partners in checkpoint signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

14-3-3 proteins: structure, function, and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

14-3-3 proteins: regulation of subcellular localization by molecular interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

14-3-3 proteins: key regulators of cell division, signalling and apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

Regulation of cell death protease caspase-9 by phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

Direct control of the Forkhead transcription factor AFX by protein kinase B

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

Type 1 insulin-like growth factor regulates MT1-MMP synthesis and tumor invasion via PI 3-kinase/Akt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

Insulin-like growth factor I induces MDM2-dependent degradation of p53 via the p38 MAPK pathway in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

The cyclin-dependent kinase inhibitor p21CIP/WAF is a positive regulator of insulin-like growth factor I-induced cell proliferation in MCF-7 human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

Cyclin D1 expression in pre-cancerous and cancerous lesions of the canine mammary gland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

Regulation of Id2 gene expression by the insulin-like growth factor I receptor requires signaling by phosphatidylinositol 3-kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

Cyclin D1 protein expression and function in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M401300200

21 January 2018

Identifiers

DOI

10.1074/JBC.M401300200

1 reference

21 September 2017

1 reference